Xiangcheng Li

4.0k total citations · 1 hit paper
111 papers, 2.1k citations indexed

About

Xiangcheng Li is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Xiangcheng Li has authored 111 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 35 papers in Hepatology and 34 papers in Oncology. Recurrent topics in Xiangcheng Li's work include Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Organ Transplantation Techniques and Outcomes (22 papers) and Liver Disease and Transplantation (16 papers). Xiangcheng Li is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Organ Transplantation Techniques and Outcomes (22 papers) and Liver Disease and Transplantation (16 papers). Xiangcheng Li collaborates with scholars based in China, United Kingdom and United States. Xiangcheng Li's co-authors include Gu‐Wei Ji, Xuehao Wang, Xuehao Wang, Mingyu Wu, Wangjie Jiang, Yaodong Zhang, Feipeng Zhu, Yongxiang Xia, Liyong Pu and Feipeng Zhu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiangcheng Li

100 papers receiving 2.1k citations

Hit Papers

Lattice compressive strai... 2025 2026 2025 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangcheng Li China 25 648 601 537 532 505 111 2.1k
Peihong Wu China 31 699 1.1× 442 0.7× 377 0.7× 953 1.8× 836 1.7× 124 2.7k
Hiroko Ikeda Japan 30 959 1.5× 539 0.9× 185 0.3× 713 1.3× 670 1.3× 130 2.5k
Fabiana Tatangelo Italy 37 653 1.0× 653 1.1× 956 1.8× 1.7k 3.2× 517 1.0× 129 3.2k
Francesco Leone Italy 26 906 1.4× 381 0.6× 228 0.4× 1.4k 2.7× 364 0.7× 134 2.5k
Qing Lü China 25 489 0.8× 282 0.5× 750 1.4× 541 1.0× 227 0.4× 124 2.2k
Matthias Hornung Germany 19 692 1.1× 717 1.2× 163 0.3× 564 1.1× 192 0.4× 62 2.2k
Yao Yu United States 22 352 0.5× 605 1.0× 235 0.4× 393 0.7× 180 0.4× 138 1.8k
Atsushi Nanashima Japan 26 1.2k 1.8× 444 0.7× 170 0.3× 685 1.3× 1.1k 2.2× 210 2.6k
Yong S. Chang United States 21 314 0.5× 1.0k 1.7× 175 0.3× 530 1.0× 189 0.4× 36 2.2k
Jun Hanaoka Japan 27 680 1.0× 566 0.9× 132 0.2× 757 1.4× 321 0.6× 202 2.3k

Countries citing papers authored by Xiangcheng Li

Since Specialization
Citations

This map shows the geographic impact of Xiangcheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangcheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangcheng Li more than expected).

Fields of papers citing papers by Xiangcheng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangcheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangcheng Li. The network helps show where Xiangcheng Li may publish in the future.

Co-authorship network of co-authors of Xiangcheng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangcheng Li. A scholar is included among the top collaborators of Xiangcheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangcheng Li. Xiangcheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Shutsung, et al.. (2025). Identification of the B7-H3 Interaction Partners Using a Proximity Labeling Strategy. International Journal of Molecular Sciences. 26(4). 1731–1731. 1 indexed citations
2.
Yang, Tao, et al.. (2025). Smoothness-Induced Efficient Incomplete Multi-View Clustering. IEEE Transactions on Knowledge and Data Engineering. 37(10). 6173–6188.
3.
Wang, Jifei, Qinfeng Xu, Hongwei Wang, et al.. (2025). Aldose reductase -mediated HUR ubiquitination enhances exosome release and hepatic fibrosis via ROS/PI3K/AKT pathway. Free Radical Biology and Medicine. 236. 1–16.
4.
Wen, Hao, Tuerganaili Aji, Zhiyu Chen, et al.. (2024). Particular Chinese contributions to extracorporeal liver surgery. Hepatobiliary & pancreatic diseases international. 24(1). 57–66.
6.
Ma, Zhanhong, et al.. (2024). Perspectives and challenges on the interaction between tropical cyclone precipitation and the ocean: A review. Atmospheric and Oceanic Science Letters. 18(2). 100573–100573.
7.
Ji, Gu‐Wei, Qing Xu, Chenyu Jiao, et al.. (2023). Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights. JHEP Reports. 5(10). 100839–100839. 3 indexed citations
9.
Ma, Zijian, Changxian Li, Wangjie Jiang, et al.. (2022). The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nature Communications. 13(1). 38 indexed citations
10.
Wang, Ziyi, Zhibo Wang, Tao Zhou, et al.. (2022). Apolipoprotein A‐1 protected hepatic ischaemia–reperfusion injury through suppressing macrophage pyroptosis via TLR4–NF‐κB pathway. Liver International. 43(1). 234–248. 19 indexed citations
11.
Chen, Xiaofeng, Wei Li, Xiaofeng Wu, et al.. (2022). Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study. Frontiers in Oncology. 12. 909035–909035. 32 indexed citations
12.
Ji, Gu‐Wei, Feipeng Zhu, Qing Xu, et al.. (2020). Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study. Radiology. 294(3). 568–579. 203 indexed citations
13.
Li, Xiangcheng & Hongwei Wang. (2018). Present situation and prospect of comprehensive treatment of hepatocellular carcinoma. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(5). 433–436. 1 indexed citations
14.
Ji, Gu‐Wei, et al.. (2018). Short‐ and long‐term outcomes of middle hepatic vein–oriented hepatectomy for advanced perihilar cholangiocarcinoma. Journal of Surgical Oncology. 118(3). 446–454. 2 indexed citations
15.
Ji, Gu‐Wei, Yu‐Dong Zhang, Hui Zhang, et al.. (2018). Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 290(1). 90–98. 162 indexed citations
16.
Ji, Gu‐Wei, et al.. (2017). Solitary Plexiform Neurofibroma of the Hepatic Artery. Journal of Gastrointestinal Surgery. 22(4). 757–758. 5 indexed citations
17.
Jiang, Runqiu, Lei Deng, Liang Zhao, et al.. (2011). miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males. Clinical Cancer Research. 17(17). 5593–5603. 64 indexed citations
18.
Yu, Yue, Ling Lü, Xiaofeng Qian, et al.. (2009). Antifibrotic Effect of Hepatocyte Growth Factor-Expressing Mesenchymal Stem Cells in Small-for-Size Liver Transplant Rats. Stem Cells and Development. 19(6). 903–914. 52 indexed citations
19.
Wang, Xuehao, Lünan Yan, Feng Zhang, et al.. (2006). Early experiences on living donor liver transplantation in China: multicenter report. Chinese Medical Journal. 119(12). 1003–1009. 14 indexed citations
20.
Le, Xiangdong, Qian Shi, Bailiang Wang, et al.. (2000). Molecular Regulation of Constitutive Expression of Interleukin-8 in Human Pancreatic Adenocarcinoma. Journal of Interferon & Cytokine Research. 20(11). 935–946. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026